1.5.2 Corticosteroids
Budesonide
Budenofalk 2mg/application foam enema
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |
Budenofalk 3mg gastro-resistant capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Microscopic colitis (collagenous or lymphocytic) |
| Gastro-intestinal system | Crohn’s disease |
Budenofalk 9mg gastro-resistant granules sachets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Microscopic colitis (collagenous or lymphocytic) |
| Gastro-intestinal system | Crohn’s disease |
Budesonide 3mg gastro-resistant modified-release capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Microscopic colitis (collagenous or lymphocytic) |
| Gastro-intestinal system | Crohn’s disease |
Budesonide 4mg suppositories
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Cortiment 9mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Entocort 2mg/100ml enema
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
Jorveza 1mg orodispersible tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Eosinophilic oesophagitis |
Prednisolone
Prednisolone 5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Gastro-intestinal system | Crohn’s disease |